SPONSOR
The University of Texas Health Science Center, Houston
Total Trials
18
Recruiting
18
Phases
Phase 4, Phase 2, Phase 2, Phase 3, Phase 1
Conditions studied: PreDiabetesChronic PainPost Traumatic Stress Disorder (PTSD)Weight GainLabor DystociaSchizophrenia and Related DisordersFocal EpilepsySports-related ConcussionSystemic SclerosisConstipation
The University of Texas Health Science Center, Houston is a clinical research sponsor with 18 registered studies on ClinicalTrials.gov, of which 18 are actively recruiting participants. Research covers conditions including PreDiabetes, Chronic Pain, Post Traumatic Stress Disorder (PTSD), Weight Gain.
The trial portfolio spans Phase 4, Phase 2, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — The University of Texas Health Science Center, Houston
How many clinical trials has The University of Texas Health Science Center, Houston sponsored?
ClinicalMetric currently tracks 18 clinical trials sponsored by The University of Texas Health Science Center, Houston, of which 18 are actively recruiting participants. These trials cover conditions including PreDiabetes, Chronic Pain, Post Traumatic Stress Disorder (PTSD). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does The University of Texas Health Science Center, Houston research focus on?
The University of Texas Health Science Center, Houston clinical trials span PreDiabetes, Chronic Pain, Post Traumatic Stress Disorder (PTSD), Weight Gain, Labor Dystocia, and additional conditions. The research pipeline includes Phase 4, Phase 2, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a The University of Texas Health Science Center, Houston clinical trial?
To participate in a The University of Texas Health Science Center, Houston trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all The University of Texas Health Science Center, Houston trials with current recruitment status updated daily.
Clinical Trials by The University of Texas Health Science Center, Houston
NCT05119179 Phase 4
Recruiting
Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes
PreDiabetes
NCT07116109
Recruiting
Neuromodulation + Prolonged Exposure Therapy: Evaluation of a Technology-Enhanced, Integrated Treatment for Pain and PTSD
Chronic Pain
NCT07325500 Phase 2
Recruiting
Incretin Microdosing for Cardiometabolic Health in People With HIV
Weight Gain
NCT06702670 Phase 2, Phase 3
Recruiting
Anticholinergics for Cervical Edema in Labor
Labor Dystocia
NCT02916810
Recruiting
Alternative Stimulation Mode and Location for Auditory Hallucination Neuromodulation Treatment
Schizophrenia and Related Disorders
NCT05981755
Recruiting
Breathing Rescue for SUDEP Prevention
Focal Epilepsy
NCT06239818
Recruiting
Assessing the Effects of Photobiomodulation on Clinical Recovery From Concussion in Adolescents
Sports-related Concussion
NCT05989763
Recruiting
Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis
Systemic Sclerosis
NCT05600738
Recruiting
Network Effects of Therapeutic Deep Brain Stimulation
Intractable Epilepsy
NCT00857922
Recruiting
Neurosciences Research Repository
Neurological Conditions
NCT05989880
Recruiting
Pilot Feasibility Trial of the SafeLM Supraglottic Airway (SGA)
Anesthesia
NCT05018663
Recruiting
Artificial Intelligence (AI) Cytopathology Trial
Pancreatic Solid Lesions
NCT04770584
Recruiting
Fear and Avoidance in PTSD Patients
Post Traumatic Stress Disorder
NCT06831136 Phase 2
Recruiting
Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma
Pancreatic Ductal Adenocarcinoma
NCT07227948 Phase 2
Recruiting
Repurposing Semaglutide for the Treatment of Cocaine Use Disorder
Cocaine Use Disorder
NCT06029062
Recruiting
tACS for Sensory Motor Recovery After Stroke
Motor Recovery
NCT06478589 Phase 2
Recruiting
Patient Priorities for Survivorship Care in Older Breast Cancer Survivors
Breast Cancer Survivorship
NCT03705715 Phase 1
Recruiting
Identifying Correlates of Brain Microglial Activation in Neuropsychiatric Syndromes: a Dimensional Approach
Neuropsychiatric Syndromes
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology